PROGRAMME
AT A GLANCE

 

Thursday, October 27, 2022

    Alpha 8 Hall Alpha 5+6 Hall Alpha 3+4 Hall Beta 6-7 RoomsBeta Room 9Offsite
    07:00-09:00
    ESGO RUN
    08:00-12:00
    Workshops 2-5    		09:00-12:00
    ESGO Exam    		08:00-12:00
    Workshop 1
    12:00-12:30
    Sandwich Lunch
    12:30-13:30
    ESGO Colloquium    		12:30-13:30
    Satellite symposium 1
    13:45-14:45
    Best oral Session 1
    14:50-15:50
    STATE OF THE ART 1:
     ESGO-ESTRO-ESP guidelines
    on cervical cancer 2022    		 14:50-15:50
    SCIENTIFIC SESSION 1:
    organised by ENYGO
    Sexual health in GO cancers    		 14:50-15:50
    Oral Posters Session 1
    15:50-16:20
    Coffee Break
    16:20-17:20
    SCIENTIFIC SESSION 2:
    Basic and advanced technical
    aspects of surgery
    for vulvar cancer surgery     		16:20-17:20
    TUMOUR BOARD 1:
    Frail patients with
    gynaecological cancer     		16:20-17:20
    VIDEO SESSION 1
    17:25-18:25
    DEBATE 1:
    Molecular classification for
    management of
    endometrial cancer    		 17:25-18:25
    SCIENTIFIC SESSION 3:
     Management of toxicity of
    immuno-oncology drugs    		 17:25-18:25
    SCIENTIFIC SESSION 4:
    organised by ENYGO
    Less Radical Surgery in
    early-stage cervical cancer
    18:30-20:30
    OPENING CEREMONY
    followed by
    WELCOME RECEPTION

Friday, October 28, 2022

    Alpha 8 HallAlpha 5+6 HallAlpha 3+4 HallAlpha 1 HallOffsite
    07:30-08:30
    Satellite Symposium 2
    08:35-09:35
    STATE OF THE ART 2:
     New ESGO-ESHRE-ESGE
    Guidelines on
    Fertility Sparing in
    Endometrial Cancer    		 08:35-09:35
    Oral Posters 2
    		 08:35-09:35
    SCIENTIFIC SESSION 5:
     Update on uterine sarcomas
    09:35-09:55
    Coffee Break
    09:55-10:55
    DEBATE 2:
     Star Wars:
    The generation fight between
    modern and conventional
    approaches of minimal
    invasive surgery in
    gynecological oncology    		 09:55-10:55
    SCIENTIFIC SESSION 6:
     Major practice changing
    studies in 2021-2022     		09:55-10:55
    SCIENTIFIC SESSION 7:
     organised by ENYGO:
    Putting the patient back
    to the centre of treatment
    11:00-12:00
    PRESIDENTIAL &
    AWARDS SESSION
    12:00-12:30
    Lunch Break
    12:30-13:30
    Satellite Symposium 3    		12:30-13:30
    Satellite Symposium 4    		 12:30-19:00
    ENGAGE
    Patient Seminar
    13:35-14:35
    Best Oral Session 2     		13:35-14:35
    SCIENTIFIC SESSION 8:
    2020’s
    A Breakthrough Decade
    for the Management of
    Gestational Trophoblastic
    Tumours    		 13:35-14:35
    TUMOUR BOARD 2:
    Rare Vulvar Carcinoma
    (melanoma-Paget)
    and Vagina Carcinoma
    14:40-15:40
    Coffee Break &
    Posters Viewing    		14:40-15:40
    Satellite Symposium 5
    15:45-16:45
    STATE OF THE ART 3:
     ESMO-ESGO-ESP
    Consensus Conference
    on ovarian cancer 2022    		 15:45-16:45
    SCIENTIFIC SESSION 9:
     Maintenance therapy in
    first-line ovarian cancer     		15:45-16:45
    Oral Posters Session 3
    16:50-17:50
    Best Three Minutes
    Presentations    		 16:50-17:50
    VIDEO SESSION 2
         		16:50-17:50
    SCIENTIFIC SESSION 10:
     ENGOT- Clinical Research
    Symposium
    18:00-19:00
    General Assembly
    20:00-22:00
    ESGO Invited Speakers
    Dinner

Saturday, October 29, 2022

    Alpha 8 HallAlpha 5+6 HallAlpha 3+4 HallAlpha 1+2 HallsAlpha1 HallOffsite
    07:15-08:15
    Meet the Expert
    at breakfast
    08:30-09:30
    STATE OF THE ART 4:
     ESGO-ESTRO
    Cervical Cancer
    Quality Indicators in
    Radiotherapy    		 08:30-09:30
    SCIENTIFIC SESSION 11:
    Rechallenging in
    ovarian cancer
    (PARPi, bevacizumab
    & surgery)    		 08:30-09:30
    SCIENTIFIC SESSION 12:
    organised by ENYGO
    SLN concept in cervical
    & endometrial cancer     		9:30-19:00
    ENGAGE
    Patient Seminar
    09:35-10:35
    DEBATE 3:
     Microinvasive surgery
    for early stage
    cervical cancer    		 09:35-10:35
    Video Session 3     		09:35-10:35
    SCIENTIFIC SESSION 13:
     Rare epithelial
    ovarian cancer
    10:35-11:00
    Coffee Break
    11:00-12:00
    Satellite Symposium 6    		11:00-12:00
    Satellite Symposium 7    		11:00-12:00
    Satellite Symposium 8
    12:00-13:00
    Lunch Break &
    Posters Viewing
    13:00-14:00
    Best Oral Session 3     		13:00-14:00
    SCIENTIFIC SESSION 14:
     Basics of Psycho-
    Oncology & empowering
    health care providers    		 13:00-14:00
    DEBATE 4:
     Different options for
    imaging in
    gynaecological cancer
    14:05-15:05
    SCIENTIFIC SESSION 15:
    ERAS in
    gynaecological cancer
    & perioperative
    management     		14:05-15:05
    Oral Poster Session 4     		14:05-15:05
    TUMOUR BOARD 3:
     Techniques and indication
    for interventional radiology
    15:05-15:30
    Coffee Break
    15:30-16:30
    SCIENTIFIC SESSION 16:
    Neoadjuvant
    chemotherapy or
    upfront trachelectomy
    in early cervical cancer    		 15:30-16:30
    SCIENTIFIC SESSION 17:
    HPV vaccines and
    HPV screening     		15:30-16:30
    Young Investigator
    Session
    organised by ENYGO
    16:35-17:35
    STATE OF THE ART 5:
     New Guidelines
    ESGO-ESTRO-SIOPE
    on vaginal cancer     		16:35-17:35
    SCIENTIFIC SESSION 18:
    When and how to
    test for HRD    		 16:35-17:35
    TUMOUR BOARD 4:
     Treatment of low grade
    serous ovarian cancer
    17:40-19:00
    GO Summit
    20:00-22:00
    ENYGO PARTY

Sunday, October 30, 2022

    Alpha 8 HallAlpha 5+6 HallsAlpha 3+4 Hall Beta 1+2+6 RoomsAlpha1 Hall
    08:30-09:30
    STATE OF THE ART 6:
    Updated ESGO guidelines
    on vulvar cancer    		 08:30-09:30
    SCIENTIFIC SESSION 19
    Secondary cytoreductive
    Surgery in recurrent
    Ovarian Cancer    		 08:30-09:30
    TUMOUR BOARD 5:
     Complex questions
    for Germ Cell Tumours
    09:30-09:50
    Coffee Break     		9:30-12:30
    ENGAGE
    Patient Seminar
    09:50-10:50
    Best Oral Session 4     		09:50-10:50
    SCIENTIFIC SESSION 20:
    Hot topics in
    translational research     		09:50-10:50
    DEBATE 5:
     Indications for concurrent
    radio-chemotherapy (RTCT)
    or neoadjuvant chemotherapy
    followed by radical surgery
    (NACT-RS) in cervical cancer
    10:55-11:55
    STATE OF THE ART 7:
    New ESGO-GCIG
    Algorithms on
    Rare Cancers     		10:55-11:55
    DEBATE 6:
     Role of HIPEC
    and IP in ovarian cancer     		10:55-11:55
    VIDEO SESSION 4
    12:00-12:30
    Closing Ceremony
    13:00-16:30
    Workshops

PDF copy of programme at a glance, as of Sep 6, 2022

The Interactive Program is now available!

*Programme is subject to change

>> Plan ahead to join us in Berlin

tab